{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:53:31Z","timestamp":1785606811902,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00415-021-10803-3","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T08:06:27Z","timestamp":1631865987000},"page":"1114-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-6267","authenticated-orcid":false,"given":"Luca","family":"Prosperini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalom","family":"Haggiag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Galgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"issue":"13","key":"10803_CR1","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMe2002387","volume":"382","author":"AS Fauci","year":"2020","unstructured":"Fauci AS, Lane HC, Redfield RR et al (2020) COVID-19\u2014navigating the Uncharted. N Engl J Med 382(13):1268\u20131269","journal-title":"N Engl J Med"},{"issue":"6","key":"10803_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1474-4422(20)30147-2","volume":"19","author":"MP Sormani","year":"2020","unstructured":"Sormani MP, Italian Study Group on COVID-19 infection in multiple sclerosis (2020) An Italian programme for COVID-19 infection in multiple sclerosis. Lancet Neurol 19(6):481\u2013482","journal-title":"Lancet Neurol"},{"issue":"1","key":"10803_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/jnnp-2020-324449","volume":"92","author":"N Evangelou","year":"2021","unstructured":"Evangelou N, Garjani A, dasNair R, et al (2021) Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register. J Neurol Neurosurg Psychiatry 92(1):107\u2013109","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10803_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14555","author":"G Bsteh","year":"2020","unstructured":"Bsteh G, Bitschnau C, Hegen H et al (2020) Multiple sclerosis and COVID-19: how many are at risk? Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14555","journal-title":"Eur J Neurol"},{"issue":"4","key":"10803_CR5","doi-asserted-by":"publisher","first-page":"e1001","DOI":"10.1212\/NXI.0000000000001001","volume":"8","author":"M Barzegar","year":"2021","unstructured":"Barzegar M, Mirmosayyeb O, Gajarzadeh M et al (2021) COVID-19 among patients with multiple sclerosis: a systematic review. Neurol Neuroimmunol Neuroinflamm 8(4):e1001","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10803_CR6","unstructured":"World Health Organization (2021) Situation reports. www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports. Accessed on 31 Jul 2021"},{"issue":"3","key":"10803_CR7","first-page":"e123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 3(3):e123\u2013e130","journal-title":"Open Med"},{"key":"10803_CR8","first-page":"1057","volume":"192","author":"D O\u2019Sullivan","year":"2013","unstructured":"O\u2019Sullivan D, Wilk S, Michalowski W et al (2013) Using PICO to align medical evidence with MDs decision making models. Stud Health Technol Inform 192:1057","journal-title":"Stud Health Technol Inform"},{"issue":"2","key":"10803_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1212\/WNL.0b013e31829a3388","volume":"81","author":"A Scalfari","year":"2013","unstructured":"Scalfari A, Knappertz V, Cutter G et al (2013) Mortality in patients with multiple sclerosis. Neurology 81(2):184\u2013192","journal-title":"Neurology"},{"issue":"3","key":"10803_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/23.3.643","volume":"23","author":"CA Carson","year":"1994","unstructured":"Carson CA, Taylor HR, McCarty DJ, Zimmet P (1994) Age-standardization in epidemiological data. Int J Epidemiol 23(3):643\u2013644","journal-title":"Int J Epidemiol"},{"key":"10803_CR11","doi-asserted-by":"publisher","first-page":"102886","DOI":"10.1016\/j.msard.2021.102886","volume":"51","author":"R Alonso","year":"2021","unstructured":"Alonso R, Silva B, Garcea O et al (2021) COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America. Mult Scler Relat Disord 51:102886","journal-title":"Mult Scler Relat Disord"},{"key":"10803_CR12","doi-asserted-by":"publisher","first-page":"103004","DOI":"10.1016\/j.msard.2021.103004","volume":"52","author":"F Alshamrani","year":"2021","unstructured":"Alshamrani F, Alnajashi H, AlJumah M et al (2021) Registry of patients with multiple sclerosis an COVID-19 infection in Saudi Arabia. Mult Scler Relat Disord 52:103004","journal-title":"Mult Scler Relat Disord"},{"key":"10803_CR13","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1212\/NXI.0000000000001024","volume":"8","author":"G Arrambide","year":"2021","unstructured":"Arrambide G, Llaneza-Gonz\u00e1lez M\u00c1, Costa-Frossard Fran\u00e7a L et al (2021) SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry. Neurol Neuroimmunol Neuroinflammation 8:e1024","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10803_CR14","doi-asserted-by":"publisher","first-page":"102276","DOI":"10.1016\/j.msard.2020.102276","volume":"45","author":"M Barzegar","year":"2020","unstructured":"Barzegar M, Mirmosayyeb O, Ghajarzadeh M et al (2020) Characteristics of COVID-19 disease in multiple sclerosis patients. Mult Scler Relat Disord 45:102276","journal-title":"Mult Scler Relat Disord"},{"key":"10803_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.17.20214429","author":"M Bayat","year":"2020","unstructured":"Bayat M, Fayyazpoor A, Haghighi AB et al (2020) SARS-CoV-2 infection among patients with multiple sclerosis: a cross-sectional study. MedRxiv. https:\/\/doi.org\/10.1101\/2020.10.17.20214429","journal-title":"MedRxiv"},{"key":"10803_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520978354","author":"DG Brum","year":"2021","unstructured":"Brum DG, Neuroimmunology Brazilian Study Group Focused on COVID-19 and MS et al (2021) Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458520978354","journal-title":"Mult Scler"},{"key":"10803_CR17","doi-asserted-by":"publisher","first-page":"e0255316","DOI":"10.1371\/journal.pone.0255316","volume":"16","author":"G Bsteh","year":"2021","unstructured":"Bsteh G, Assar H, Hegen H et al (2021) COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: insights from a nation-wide Austrian registry. PLoS ONE 16:e0255316","journal-title":"PLoS ONE"},{"key":"10803_CR18","doi-asserted-by":"publisher","first-page":"117147","DOI":"10.1016\/j.jns.2020.117147","volume":"418","author":"F Chaudhry","year":"2020","unstructured":"Chaudhry F, Bulka H, Rathnam AS et al (2020) COVID-19 in multiple sclerosis patients and risk factors for severe infection. J Neurol Sci 418:117147","journal-title":"J Neurol Sci"},{"key":"10803_CR19","doi-asserted-by":"publisher","first-page":"102392","DOI":"10.1016\/j.msard.2020.102392","volume":"45","author":"E Ciampi","year":"2020","unstructured":"Ciampi E, Uribe-San-Mart\u00edn R, Soler B et al (2020) COVID-19 in MS and NMOSD: a multicentric online national survey in Chile. Mult Scler Relat Disord 45:102392","journal-title":"Mult Scler Relat Disord"},{"key":"10803_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5603\/PJNNS.a2021.0031","volume":"55","author":"A Czarnowska","year":"2021","unstructured":"Czarnowska A, Brola W, Zajkowska O et al (2021) Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies\u2014the Polish experience. Neurol Neurochir Pol 55:11","journal-title":"Neurol Neurochir Pol"},{"key":"10803_CR21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1177\/1352458520942198","volume":"26","author":"FC Loonstra","year":"2020","unstructured":"Loonstra FC, Hoitsma E, van Kempen ZL et al (2020) COVID-19 in multiple sclerosis: the Dutch experience. Mult Scler 26:1256\u20131260","journal-title":"Mult Scler"},{"issue":"9","key":"10803_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/jamaneurol.2020.2581","volume":"77","author":"C Louapre","year":"2020","unstructured":"Louapre C, Collongues N, Stankoff B et al (2020) Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurol 77(9):1079\u20131088","journal-title":"JAMA Neurol"},{"key":"10803_CR23","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1212\/NXI.0000000000000835","volume":"7","author":"E Parrotta","year":"2020","unstructured":"Parrotta E, Kister I, Charvet L et al (2020) COVID-19 outcomes in MS: observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center. Neurol Neuroimmunol Neuroinflammation 7:e835","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10803_CR24","doi-asserted-by":"publisher","first-page":"102472","DOI":"10.1016\/j.msard.2020.102472","volume":"46","author":"MA Sahraian","year":"2020","unstructured":"Sahraian MA, Azimi A, Navardi S et al (2020) Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis. Mult Scler Relat Disord 46:102472","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10803_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jamaneurol.2021.0688","volume":"78","author":"A Salter","year":"2021","unstructured":"Salter A, Fox RJ, Newsome SD et al (2021) Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis. JAMA Neurol 78(6):699\u2013708","journal-title":"JAMA Neurol"},{"key":"10803_CR26","doi-asserted-by":"publisher","first-page":"102968","DOI":"10.1016\/j.msard.2021.102968","volume":"52","author":"S Sen","year":"2021","unstructured":"Sen S, Karabudak R, Schiavetti I et al (2021) The outcome of a national MS-Covid-19 study: what the Turkish MS cohort reveals? Mult Scler Relat Disord 52:102968","journal-title":"Mult Scler Relat Disord"},{"key":"10803_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.26028","volume":"89","author":"MP Sormani","year":"2021","unstructured":"Sormani MP, De Rossi N, Schiavetti I et al (2021) Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol 89:780\u2013789","journal-title":"Ann Neurol"},{"key":"10803_CR28","doi-asserted-by":"publisher","first-page":"103104","DOI":"10.1016\/j.msard.2021.103104","volume":"54","author":"D Stastna","year":"2021","unstructured":"Stastna D, Menkyova I, Drahota J et al (2021) Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: a pandemic year in Czechia. Mult Scler Relat Disord 54:103104","journal-title":"Mult Scler Relat Disord"},{"key":"10803_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40263-021-00804-1","volume":"35","author":"AT Reder","year":"2021","unstructured":"Reder AT, Centonze D, Naylor ML et al (2021) COVID-19 in patients with multiple sclerosis: associations with disease-modifying therapies. CNS Drugs 35:317\u2013330","journal-title":"CNS Drugs"},{"key":"10803_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","volume":"184","author":"A Sokal","year":"2021","unstructured":"Sokal A, Chappert P, Barba-Spaeth G et al (2021) Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 184:1201\u20131213","journal-title":"Cell"},{"key":"10803_CR31","first-page":"1","volume":"12","author":"D Centonze","year":"2021","unstructured":"Centonze D, Rocca MA, Gasperini C et al (2021) Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus. J Neurol 12:1\u22128","journal-title":"J Neurol"},{"issue":"10","key":"10803_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1177\/1352458520941485","volume":"26","author":"LM Peeters","year":"2020","unstructured":"Peeters LM, Parciak T, Walton C et al (2020) COVID-19 in people with multiple sclerosis: a global data sharing initiative. Mult Scler 26(10):1157\u20131162","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10803-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T22:18:00Z","timestamp":1645222680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10803-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10803"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10803-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to report relevant to the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}